BDWM
Brewin Dolphin Wealth Management Portfolio holdings
AUM
$917M
This Quarter Return
+3.33%
1 Year Return
-12.35%
3 Year Return
+47.72%
5 Year Return
+88.18%
10 Year Return
–
AUM
$144M
AUM Growth
–
Cap. Flow
+$144M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
51.94%
Holding
157
New
157
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$16.9M |
| 2 |
Johnson & Johnson
JNJ
|
$10.7M |
| 3 |
Microsoft
MSFT
|
$9.72M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$8.91M |
| 5 |
Vanguard Information Technology ETF
VGT
|
$7.57M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 17.83% |
| 2 | Consumer Staples | 17.62% |
| 3 | Healthcare | 16.97% |
| 4 | Technology | 10.71% |
| 5 | Industrials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
151
Amarin Corp
AMRN
$311M
| $2.8K | ﹤0.01% |
+800
| New | +$2.8K |
|
152
Liberty Latin America Class C
LILAK
$1.65B
| $1.47K | ﹤0.01% |
+63
| New | +$1.47K |
|
153
Stratasys
SSYS
$906M
| $1.16K | ﹤0.01% |
+50
| New | +$1.16K |
|
154
CEVA Inc
CEVA
$531M
| $899 | ﹤0.01% |
+21
| New | +$899 |
|
|
155
Liberty Latin America Class A
LILA
$1.61B
| $594 | ﹤0.01% |
+25
| New | +$594 |
|
156
Achieve Life Sciences
ACHV
$152M
| $18 | ﹤0.01% |
+9
| New | +$18 |
|
157
Phio Pharmaceuticals
PHIO
$11.3M
| $5 | ﹤0.01% |
+10
| New | +$5 |
|